Online Appendix for the following June 21 JACC article
TITLE: Is the Association Between Flow-Mediated Dilation and Cardiovascular Risk
Limited to Low-Risk Populations?
AUTHORS: Daniel R. Witte, MD, PhD, Julius Center for Health Sciences and
Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands, J.
Westerink, MD, Department of Internal Medicine, Section of Vascular Medicine,
Diabetes and Endocrinology, University Medical Center Utrecht, Utrecht, the
Netherlands, Eelco J. de Koning, MD, PhD, Department of Internal Medicine, Section
of Vascular Medicine, Diabetes and Endocrinology, University Medical Center
Utrecht, Utrecht, the Netherlands, and the Department of Internal Medicine, Section
of Nephrology, Leids University Medical Center, Leiden, the Netherlands, Yolanda
van der Graaf, MD, PhD, Julius Center for Health Sciences and Primary Care,
University Medical Center Utrecht, Utrecht, the Netherlands, Diederick E. Grobbee,
MD, PhD, Julius Center for Health Sciences and Primary Care, University Medical
Center Utrecht, Utrecht, the Netherlands, Michiel L. Bots, MD, PhD, Julius Center for
Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the
Netherlands
APPENDIX
References: Meta-Analysis
1.
Zhang X, Zhao SP, Li XP, Gao M, Zhou QC. Endothelium-dependent and -
independent functions are impaired in patients with coronary heart disease.
Atherosclerosis 2000;149:19–24.
2.
Hashimoto M, Akishita M, Eto M, et al. Modulation of endothelium-
dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle.
Circulation 1995;92:3431–5.
3.
Lekakis J, Mavrikakis M, Papamichael C, et al. Short-term estrogen
administration improves abnormal endothelial function in women with systemic
sclerosis and Raynaud’s phenomenon. Am Heart J. 1998;136:905–12.
4.
Chambers JC, Ueland PM, Obeid OA, Wrigley J, Refsum H, Kooner JS.
Improved vascular endothelial function after oral B vitamins: an effect mediated
through reduced concentrations
of free plasma homocysteine. Circulation
2000;102:2479–83.
5.
Lambert J, Aarsen M, Donker AJ, Stehouwer CD. Endothelium-dependent and
-independent vasodilation of large arteries in normoalbuminuric insulin-dependent
diabetes mellitus. Arterioscler Thromb Vasc Biol 1996;16:705–11.
6.
Celermajer DS, Adams MR, Clarkson P, et al. Passive smoking and impaired
endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med
1996;334:150–4.
7.
McCrohon JA, Adams MR, McCredie RJ, et al. Hormone replacement therapy
is associated with improved arterial physiology in healthy post-menopausal women.
Clin Endocrinol (Oxf) 1996;45:435–41.
8.
Simons LA, von Konigsmark M, Simons J, Stocker R, Celermajer DS.
Vitamin E ingestion does not improve arterial endothelial dysfunction in older adults.
Atherosclerosis 1999;143:193–9.
9.
Chambers JC, McGregor A, Jean-Marie J, Obeid OA, Kooner JS.
Demonstration
of
rapid
onset
vascular
endothelial
dysfunction
after
hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation
1999;99:1156–60.
10.
Raitakari OT, Adams MR, Celermajer DS. Effect of Lp(a) on the early
functional and structural changes of atherosclerosis. Arterioscler Thromb Vasc Biol
1999;19:990–5.
11.
Koh KK, Kang MH, Jin DK, et al. Vascular effects of estrogen in type II
diabetic postmenopausal women. J Am Coll Cardiol 2001;38:1409–15.
12.
Plotnick GD, Corretti MC, Vogel RA. Effect of antioxidant vitamins on the
transient impairment of endothelium-dependent brachial artery vasoactivity following
a single high-fat meal. JAMA 1997;278:1682–6.
13.
Vogel RA, Corretti MC, Plotnick GD. Changes in flow-mediated brachial
artery vasoactivity with lowering of desirable cholesterol levels in healthy middleaged men. Am J Cardiol 1996;77:37–40.
14.
Toikka JO, Ahotupa M, Viikari JS, et al. Constantly low HDL-cholesterol
concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation
in healthy young men. Atherosclerosis 1999;147:133–8.
15.
de Valk-de Roo GW, Stehouwer CD, Lambert J, et al. Plasma homocysteine is
weakly correlated with plasma endothelin and von Willebrand factor but not with
endothelium-dependent vasodilatation in healthy postmenopausal women. Clin Chem
1999;45:1200–5.
16.
McFarlane R, McCredie RJ, Bonney MA, et al. Angiotensin converting
enzyme inhibition and arterial endothelial function in adults with type 1 diabetes
mellitus. Diabet Med 1999;16:62–6.
17.
Dupuis J, Tardif JC, Cernacek P, Theroux P. Cholesterol reduction rapidly
improves endothelial function after acute coronary syndromes. The RECIFE
(Reduction of Cholesterol in Ischemia and Function of the Endothelium) trial.
Circulation 1999;99:3227–33.
18.
Etsuda H, Takase B, Uehata A, et al. Morning attenuation of endothelium-
dependent, flow-mediated dilation in healthy young men: possible connection to
morning peak of cardiac events? Clin Cardiol 1999;22:417–21.
19.
Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is
associated with dose-related and potentially reversible impairment of endotheliumdependent dilation in healthy young adults. Circulation 1993;88:2149–55.
20.
Bae JH, Bassenge E, Kim KB, et al. Postprandial hypertriglyceridemia impairs
endothelial function by enhanced oxidant stress. Atherosclerosis 2001;155:517–23.
21.
Anderson RA, Evans ML, Ellis GR, et al. The relationships between post–
prandial lipaemia, endothelial function and oxidative stress in healthy individuals and
patients with type 2 diabetes. Atherosclerosis 2001;154:475–83.
22.
Marchesi S, Lupattelli G, Schillaci G, et al. Impaired flow-mediated
vasoactivity during post-prandial phase in young healthy men. Atherosclerosis
2000;153:397–402.
23.
Wilmink HW, de Kleijn MJ, Bots ML, et al. Lipoprotein (a) is associated with
endothelial
function
2000;153:249–54.
in
healthy
postmenopausal
women.
Atherosclerosis
24.
Patel AR, Kuvin JT, Pandian NG, et al. Heart failure etiology affects
peripheral vascular endothelial function after cardiac transplantation. J Am Coll
Cardiol 2001;37:195–200.
25.
Raitakari OT, Lai N, Griffiths K, McCredie R, Sullivan D, Celermajer DS.
Enhanced peripheral vasodilation in humans after a fatty meal. J Am Coll Cardiol
2000;36:417–22.
26.
Sader MA, Griffiths KA, McCredie RJ, Handelsman DJ, Celermajer DS.
Androgenic anabolic steroids and arterial structure and function in male bodybuilders.
J Am Coll Cardiol 2001;37:224–30.
27.
Thambyrajah J, Landray MJ, Jones HJ, McGlynn FJ, Wheeler DC, Townend
JN. A randomized double-blind placebo-controlled trial of the effect of homocysteinelowering therapy with folic acid on endothelial function in patients with coronary
artery disease. J Am Coll Cardiol 2001;37:1858–63.
28.
Woo KS, Chook P, Leong HC, Huang XS, Celermajer DS. The impact of
heavy passive smoking on arterial endothelial function in modernized Chinese. J Am
Coll Cardiol 2000;36:1228–32.
29.
Anderson TJ, Elstein E, Haber H, Charbonneau F. Comparative study of ACE-
inhibition, angiotensin II antagonism, and calcium channel blockade on flowmediated vasodilation in patients with coronary disease (BANFF study). J Am Coll
Cardiol 2000;35:60–6.
30.
Title LM, Cummings PM, Giddens K, Nassar BA. Oral glucose loading
acutely attenuates endothelium-dependent vasodilation in healthy adults without
diabetes: an effect prevented by vitamins C and E. J Am Coll Cardiol 2000;36:2185–
91.
31.
Barenbrock M, Hausberg M, Kosch M, Golubev SA, Kisters K, Rahn KH.
Flow-mediated vasodilation and distensibility in relation to intima-media thickness of
large arteries in mild essential hypertension. Am J Hypertens 1999;12:973–9.
32.
Hashimoto M, Eto M, Akishita M, et al. Correlation between flow-mediated
vasodilatation of the brachial artery and intima-media thickness in the carotid artery in
men. Arterioscler Thromb Vasc Biol 1999; 19:2795–800.
33.
van Guldener C, Janssen MJ, Lambert J, et al. No change in impaired
endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in
haemodialysis patients. Nephrol Dial Transplant 1998;13:106–12.
34.
Simons LA, von Konigsmark M, Simons J, Celermajer DS. Phytoestrogens do
not influence lipoprotein levels or endothelial function in healthy, postmenopausal
women. Am J Cardiol 2000;85:1297–301.
35.
Hijmering ML, Stroes ES, Pasterkamp G, Sierevogel M, Banga JD, Rabelink
TJ. Variability of flow-mediated dilation: consequences for clinical application.
Atherosclerosis 2001;157:369–73.
36.
Alonso R, Mata P, De Andres R, Villacastin BP, Martinez-Gonzalez J,
Badimon L. Sustained long-term improvement of arterial endothelial function in
heterozygous familial hypercholesterolemia patients treated with simvastatin.
Atherosclerosis 2001;157:423–9.
37.
de Roos NM, Bots ML, Katan MB. Replacement of dietary saturated fatty
acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial
function in healthy men and women. Arterioscler Thromb Vasc Biol 2001;21:1233–7.
38.
Enderle MD, Schroeder S, Ossen R, et al. Comparison of peripheral
endothelial dysfunction and intimal media thickness in patients with suspected
coronary artery disease. Heart 1998;80:349–54.
39.
Jodoin I, Bussieres LM, Tardif JC, Juneau M. Effect of a short-term primary
prevention program on endothelium-dependent vasodilation in adults at risk for
atherosclerosis. Can J Cardiol 1999;15:83–8.
40.
Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial
function in the human coronary and peripheral circulations. J Am Coll Cardiol
1995;26:1235–41.
41.
de Kleijn MJ, Wilmink HW, Bots ML, et al. Hormone replacement therapy
and endothelial function. Results of a randomized controlled trial in healthy
postmenopausal women. Atherosclerosis 2001; 159:357–65.
42.
Spieker LE, Sudano I, Hurlimann D, et al. High–density lipoprotein restores
endothelial function in hypercholesterolemic men. Circulation 2002;105:1399–402.
43.
Diercks GF, Stroes ES, van Boven AJ, et al. Urinary albumin excretion is
related to cardiovascular risk indicators, not to flow-mediated vasodilation, in
apparently healthy subjects. Atherosclerosis 2002;163:121–6.
44.
de Jongh S, Lilien MR, Bakker HD, Hutten BA, Kastelein JJ, Stroes ES.
Family history of cardiovascular events and endothelial dysfunction in children with
familial hypercholesterolemia. Atherosclerosis 2002;163:193–7.
45.
Clarkson P, Celermajer DS, Powe AJ, Donald AE, Henry RM, Deanfield JE.
Endothelium-dependent dilatation is impaired in young healthy subjects with a family
history of premature coronary disease. Circulation 1997;96:3378–83.
46.
Furumoto T, Fujii S, Saito N, Mikami T, Kitabatake A. Relationships between
brachial artery flow mediated dilation and carotid artery intima-media thickness in
patients with suspected coronary artery disease. Jpn Heart J 2002;43:117–25.
47.
van Venrooij FV, van de Ree MA, Bots ML, Stolk RP, Huisman MV, Banga
JD. Aggressive lipid lowering does not improve endothelial function in type 2
diabetes: the Diabetes Atorvastatin Lipid Intervention (DALI) Study: a randomized,
double-blind, placebo-controlled trial. Diabetes Care 2002;25:1211–6.
48.
Yataco AR, Corretti MC, Gardner AW, Womack CJ, Katzel LI. Endothelial
reactivity and cardiac risk factors in older patients with peripheral arterial disease. Am
J Cardiol 1999;83:754–8.
49.
Lambert J, van den BM, Steyn M, Rauwerda JA, Donker AJ, Stehouwer CD.
Familial hyperhomocysteinaemia and endothelium-dependent vasodilatation and
arterial distensibility of large arteries. Cardiovasc Res 1999;42:743–51.
50.
Jarvisalo MJ, Ronnemaa T, Volanen I, et al. Brachial artery dilatation
responses in healthy children and adolescents. Am J Physiol Heart Circ Physiol
2002;282:H87–92.
51.
Kosch M, Hausberg M, Vormbrock K, Kisters K, Rahn KH, Barenbrock M.
Studies on flow-mediated vasodilation and intima-media thickness of the brachial
artery in patients with primary hyperparathyroidism. Am J Hypertens 2000;13:759–
64.
52.
Jensen-Urstad K, Johansson J. Gender difference in age-related changes in
vascular function. J Intern Med 2001;250:29–36.
53.
Aggoun Y, Bonnet D, Sidi D, et al. Arterial mechanical changes in children
with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2000;20:2070–5.
54.
Jarvisalo MJ, Harmoinen A, Hakanen M, et al. Elevated serum C-reactive
protein levels and early arterial changes in healthy children. Arterioscler Thromb
Vasc Biol 2002;22:1323–8.
55.
Teragawa H, Fukuda Y, Matsuda K, et al. Effect of alcohol consumption on
endothelial function in men with coronary artery disease. Atherosclerosis
2002;165:145–52.
56.
Monnink SH, van Haelst PL, van Boven AJ, et al. Endothelial dysfunction in
patients with coronary artery disease: a comparison of three frequently reported tests.
J Investig Med 2002;50:19–24.
57.
Ravikumar R, Deepa R, Shanthirani C, Mohan V. Comparison of carotid
intima–media thickness, arterial stiffness, and brachial artery flow mediated dilatation
in diabetic and nondiabetic subjects (The Chennai Urban Population Study [CUPS9]). Am J Cardiol 2002;90:702–7.
58.
Weidinger F, Frick M, Alber HF, Ulmer H, Schwarzacher SP, Pachinger O.
Association of wall thickness of the brachial artery measured with high-resolution
ultrasound with risk factors and coronary artery disease. Am J Cardiol 2002;89:1025–
9.
59.
Dalli E, Segarra L, Ruvira J, et al. [Brachial artery flow-mediated dilation in
healthy men, men with risk factors, and men with acute myocardial infarction.
Importance of occlusion-cuff position]. Rev Esp Cardiol 2002;55:928–35.
60.
Andrews TC, Whitney EJ, Green G, Kalenian R, Personius BE. Effect of
gemfibrozil +/– niacin +/– cholestyramine on endothelial function in patients with
serum low–density lipoprotein cholesterol levels <160 mg/dl and high-density
lipoprotein cholesterol levels <40 mg/dl. Am J Cardiol 1997;80:831–5.
61.
Barua RS, Ambrose JA, Eales-Reynolds LJ, DeVoe MC, Zervas JG, Saha DC.
Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired
endothelium-dependent vasodilatation. Circulation 2001;104:1905–10.
62.
Botker HE, Sonne HS, Sorensen KE. Frequency of systemic microvascular
dysfunction in syndrome X and in variant angina. Am J Cardiol 1996;78:182–6.
63.
Park JB, Charbonneau F, Schiffrin EL. Correlation of endothelial function in
large and small arteries in human essential hypertension. J Hypertens. 2001;19:415–
20.
64.
Ghiadoni L, Donald AE, Cropley M, et al. Mental stress induces transient
endothelial dysfunction in humans. Circulation 2000;102:2473–8.
65.
Evans LM, Davies JS, Goodfellow J, Rees JA, Scanlon MF. Endothelial
dysfunction in hypopituitary adults with growth hormone deficiency. Clin Endocrinol
(Oxf) 1999;50:457–64.
66.
Dhillon R, Clarkson P, Donald AE, et al. Endothelial dysfunction late after
Kawasaki disease. Circulation 1996;94:2103–6.
67.
Wilmink HW, Twickler MB, Banga JD, et al. Effect of statin versus fibrate on
postprandial endothelial dysfunction: role of remnant-like particles. Cardiovasc Res
2001;50:577–82.
68.
Wilson DG, Bellamy MF, Ramsey MW, et al. Endothelial function in Marfan
syndrome:
selective impairment
of flow-mediated vasodilation.
Circulation
1999;99:909–15.
69.
Woo KS, Chook P, Lolin YI, Sanderson JE, Metreweli C, Celermajer DS.
Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.
J Am Coll Cardiol 1999;34:2002–6.
70.
Stein JH, Carlsson CM, Papcke-Benson K, et al. The effects of lipid-lowering
and antioxidant vitamin therapies on flow-mediated vasodilation of the brachial artery
in older adults with hypercholesterolemia. J Am Coll Cardiol 2001;38:1806–13.
71.
Tawakol
A,
Omland
T,
Gerhard
M,
Wu
JT,
Creager
MA.
Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent
vasodilation in humans. Circulation 1997;95:1119–21.
72.
Woo KS, Chook P, Lolin YI, et al. Hyperhomocyst(e)inemia is a risk factor
for arterial endothelial dysfunction in humans. Circulation 1997;96:2542–4.
73.
Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S, Imaizumi T. Endothelial
dysfunction by acute hyperhomocyst(e)inaemia: restoration by folic acid. Clin Sci
(Lond) 1999;96:235–9.
74.
Stein JH, Klein MA, Bellehumeur JL, et al. Use of human immunodeficiency
virus–1 protease inhibitors is associated with atherogenic lipoprotein changes and
endothelial dysfunction. Circulation 2001;104:257–62.
75.
Watts GF, Herrmann S, Dogra GK, et al. Vascular function of the peripheral
circulation in patients with nephrosis. Kidney Int. 2001;60:182–9.
76.
Williams MJ, Sutherland WH, McCormick MP, de Jong SA, Walker RJ,
Wilkins GT. Impaired endothelial function following a meal rich in used cooking fat.
J Am Coll Cardiol 1999;33:1050–5.
77.
Kawano H, Motoyama T, Hirai N, et al. Effect of medroxyprogesterone
acetate plus estradiol on endothelium-dependent vasodilation in postmenopausal
women. Am J Cardiol 2001;87:238–40.
78.
Schalkwijk CG, Smulders RA, Lambert J, Donker AJ, Stehouwer CD. ACE-
inhibition modulates some endothelial functions in healthy subjects and in
normotensive type 1 diabetic patients. Eur J Clin Invest 2000;30:853–60.
79.
Williams MJ, Sutherland WH, McCormick MP, de Jong SA, McDonald JR,
Walker RJ. Vitamin C improves endothelial dysfunction in renal allograft recipients.
Nephrol Dial Transplant 2001;16:1251–5.
80.
Worboys S, Kotsopoulos D, Teede H, McGrath B, Davis SR. Evidence that
parenteral testosterone therapy may improve endothelium-dependent and -
independent vasodilation in postmenopausal women already receiving estrogen. J Clin
Endocrinol Met 2001;86:158–61.
81.
The CAG repeat polymorphism in the AR gene affects high density
lipoprotein cholesterol and arterial vasoreactivity. J Clin Endocrinol Met
2001;86:4867–73.
82.
Nightingale AK, Blackman DJ, Ellis GR, et al. Preservation of venous
endothelial function in the forearm venous capacitance bed of patients with chronic
heart failure despite arterial endothelial dysfunction. J Am Coll Cardiol
2001;37:1062–8.
83.
Brook RD, Bard RL, Rubenfire M, Ridker PM, Rajagopalan S. Usefulness of
visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy
overweight adults. Am J Cardiol 2001;88:1264–9.
84.
Cagnacci A, Modena MG, Malmusi S, Muia N, Volpe A. Effect of prolonged
administration of transdermal estradiol on flow-mediated endothelium-dependent and
endothelium-independent vasodilation in healthy postmenopausal women. Am J
Cardiol 1999;84:367–10.
85.
Chambers JC, Obeid OA, Kooner JS. Physiological increments in plasma
homocysteine induce vascular endothelial dysfunction in normal human subjects.
Arterioscler Thromb Vasc Biol 1999;19:2922–7.
86.
Chambers JC, Haskard DO, Kooner JS. Vascular endothelial function and
oxidative stress mechanisms in patients with Behcet’s syndrome. J Am Coll Cardiol
2001;37:517–20.
87.
Chao
CL,
Kuo
TL,
Lee
YT.
Effects
of
methionine-induced
hyperhomocysteinemia on endothelium-dependent vasodilation and oxidative status
in healthy adults. Circulation 2000;101:485–90.
88.
Cheetham C, O’Driscoll G, Stanton K, Taylor R, Green D. Losartan, an
angiotensin type I receptor antagonist, improves conduit vessel endothelial function in
type II diabetes. Clin Sci (Lond) 2001;100:13–7.
89.
Clarke SC, Schofield PM, Grace AA, Metcalfe JC, Kirschenlohr HL.
Tamoxifen effects on endothelial function and cardiovascular risk factors in men with
advanced atherosclerosis. Circulation 2001;103:1497–502.
90.
Clarkson P, Celermajer DS, Donald AE, et al. Impaired vascular reactivity in
insulin-dependent diabetes mellitus is related to disease duration and low density
lipoprotein cholesterol levels. J Am Coll Cardiol 1996;28:573–9.
91.
Corretti MC, Plotnick GD, Vogel RA. Correlation of cold pressor and flow-
mediated brachial artery diameter responses with the presence of coronary artery
disease. Am J Cardiol 1995;75:783–7.
92.
Corretti MC, Plotnick GD, Vogel RA. Smoking correlates with flow–mediated
brachial artery vasoactivity but not cold pressor vasoactivity in men with coronary
artery disease. Int J Card Imaging 1998;14:11–7.
93.
Li J, Zhao SP, Li XP, Zhuo QC, Gao M, Lu SK. Non-invasive detection of
endothelial dysfunction in patients with essential hypertension. Int J Cardiol
1997;61:165–9.
94.
Li XP, Zhao SP, Zhang XY, Liu L, Gao M, Zhou QC. Protective effect of high
density lipoprotein on endothelium-dependent vasodilatation. Int J Cardiol
2000;73:231–6.
95.
Lekakis J, Papamichael C, Anastasiou H, et al. Endothelial dysfunction of
conduit arteries in insulin-dependent diabetes mellitus without microalbuminuria.
Cardiovasc Res 1997;34 :164–8.
96.
Lin CL, Fang TC, Gueng MK. Vascular dilatory functions of ovo-
lactovegetarians compared with omnivores. Atherosclerosis 2001;158:247–51.
97.
Mullen MJ, Clarkson P, Donald AE, et al. Effect of enalapril on endothelial
function in young insulin-dependent diabetic patients: a randomized, double-blind
study. J Am Coll Cardiol 1998;31:1330–5.
98.
Mullen MJ, Wright D, Donald AE, Thorne S, Thomson H, Deanfield JE.
Atorvastatin but not L-arginine improves endothelial function in type I diabetes
mellitus: a double-blind study. J Am Coll Cardiol 2000;36:410–6.
99.
Meco JF, Vila R, Pujol R, et al. Improvement in endothelial dysfunction in
patients with hypoalphalipoproteinemia and coronary artery disease treated with
bezafibrate. J Cardiovasc Pharmacol 2001;38:250–8.
100.
Maiorana A, O'Driscoll G, Cheetham C, Dembo L, Stanton K, Goodman C et
al. The effect of combined aerobic and resistance exercise training on vascular
function in type 2 diabetes. J Am Coll Cardiol 2001;38:860–6.
101.
Maiorano G, Bartolomucci F, Contursi V, et al. Noninvasive detection of
vascular dysfunction in alcoholic patients. Am J Hypertens 1999;12:137–44.
102.
Dogra G, Rich L, Stanton K, Watts GF. Endothelium-dependent and
independent vasodilation studies at normoglycaemia in type I diabetes mellitus with
and without microalbuminuria. Diabetologia 2001;44:593–601.
103.
Doshi SN, Naka KK, Payne N, et al. Flow-mediated dilatation following wrist
and upper arm occlusion in humans: the contribution of nitric oxide. Clin.Sci.(Lond)
2001;101:629–35.
104.
Duffy SJ, Keaney JF, Jr., Holbrook M, et al. Short- and long-term black tea
consumption reverses endothelial dysfunction in patients with coronary artery disease.
Circulation 2001;104:151–6.
105.
Ebenbichler CF, Sturm W, Ganzer H, et al. Flow-mediated, endothelium-
dependent vasodilatation is impaired in male body builders taking anabolicandrogenic steroids. Atherosclerosis 2001;158:483–90.
106.
Guzic-Salobir B, Keber I, Seljeflot I, Arnesen H, Vrabic L. Combined
hormone
replacement
therapy
improves
endothelial
function
in
healthy
postmenopausal women. J Intern Med 2001;250:508–15.
107.
Gokce N, Holbrook M, Duffy SJ, et al. Effects of race and hypertension on
flow-mediated
and
nitroglycerin-mediated
dilation
of
the
brachial
artery.
Hypertension 2001;38:1349–54.
108.
Gaenzer H, Neumayr G, Marschang P, Sturm W, Kirchmair R, Patsch JR.
Flow-mediated vasodilation of the femoral and brachial artery induced by exercise in
healthy nonsmoking and smoking men. J Am Coll Cardiol 2001;38:1313–9.
109.
Hausberg M, Kosch M, Stam F, et al. Effect of fluvastatin on endothelium-
dependent brachial artery vasodilation in patients after renal transplantation. Kidney
Int. 2001;59:1473–9.
110.
Kawano H, Motoyama T, Kugiyama K, et al. Gender difference in
improvement of endothelium-dependent vasodilation after estrogen supplementation.
J Am Coll Cardiol 1997;30:914–9.
111.
New G, Timmins KL, Duffy SJ, et al. Long-term estrogen therapy improves
vascular function in male to female transsexuals. J Am Coll Cardiol 1997;29:1437–
44.
112.
Neunteufl T, Priglinger U, Heher S, et al. Effects of vitamin E on chronic and
acute endothelial dysfunction in smokers. J Am Coll Cardiol 2000;35:277–83.
113.
Hirai N, Kawano H, Hirashima O, et al. Insulin resistance and endothelial
dysfunction in smokers: effects of vitamin C. Am J Physiol Heart Circ Physiol
2000;279:H1172–8.
114.
Savvidou MD, Vallance PJ, Nicolaides KH, Hingorani AD. Endothelial nitric
oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy.
Hypertension 2001;38:1289–93.
115.
Prasad A, Tupas-Habib T, Schenke WH, et al. Acute and chronic angiotensin-
1 receptor antagonism reverses endothelial dysfunction in atherosclerosis. Circulation
2000;101:2349–54.
116.
McCredie RJ, McCrohon JA, Turner L, Griffiths KA, Handelsman DJ,
Celermajer DS. Vascular reactivity is impaired in genetic females taking high-dose
androgens. J Am Coll Cardiol 1998;32:1331–5.
117.
Saitta A, Altavilla D, Cucinotta D, et al. Randomized, double-blind, placebo-
controlled study on effects of raloxifene and hormone replacement therapy on plasma
no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in
postmenopausal women. Arterioscler Thromb Vasc Biol 2001;21:1512–9.
118.
Koh KK, Jin DK, Yang SH, et al. Vascular effects of synthetic or natural
progestagen combined with conjugated equine estrogen in healthy postmenopausal
women. Circulation 2001;103:1961–6.
119.
Kaku B, Mizuno S, Ohsato K, et al. The correlation between coronary stenosis
index and flow-mediated dilation of the brachial artery. Jpn Circ J 1998;62:425–30.
120.
Kawano H, Motoyama T, Hirai N, Kugiyama K, Ogawa H, Yasue H. Estradiol
supplementation suppresses hyperventilation-induced attacks in postmenopausal
women with variant angina. J Am Coll Cardiol 2001;37:735–40.
121.
Wakatsuki
A,
medroxyprogesterone
Okatani
acetate
Y,
on
Ikenoue
N,
Fukaya
endothelium-dependent
T.
Effect
of
vasodilation
in
postmenopausal women receiving estrogen. Circulation 2001;104:1773–8.
122.
Lavrencic A, Salobir BG, Keber I. Physical training improves flow-mediated
dilation in patients with the polymetabolic syndrome. Arterioscler Thromb Vasc Biol
2000;20:551–5.
123.
Lee SJ, Lee DW, Kim KS, Lee IK. Effect of estrogen on endothelial
dysfunction in postmenopausal women with diabetes. Diabetes Res Clin Pract
2001;54 Suppl 2:S81–92.
124.
Imamura M, Biro S, Kihara T, et al. Repeated thermal therapy improves
impaired vascular endothelial function in patients with coronary risk factors. J Am
Coll Cardiol 2001;38:1083–8.
125.
Johansson J, Jensen-Urstad K, Jensen-Urstad M. Antiplasmin correlates to
arterial reactivity in a healthy population of 35-year-old men and women. J Intern
Med 1999;245:21–9.
126.
Neunteufl T, Heher S, Kostner K, et al. Contribution of nicotine to acute
endothelial dysfunction in long-term smokers. J Am Coll Cardiol 2002;39:251–6.
127.
Adams MR, McCredie R, Jessup W, Robinson J, Sullivan D, Celermajer DS.
Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte
adhesion to endothelial cells in young men with coronary artery disease.
Atherosclerosis 1997;129:261–9.
128.
Adams MR, Forsyth CJ, Jessup W, Robinson J, Celermajer DS. Oral L-
arginine inhibits platelet aggregation but does not enhance endothelium-dependent
dilation in healthy young men. J Am Coll Cardiol 1995;26:1054–61.
129.
Allen JD, Wilson JB, Tulley RT, Lefevre M, Welsch MA. Influence of age
and normal plasma fibrinogen levels on flow-mediated dilation in healthy adults. Am
J Cardiol 2000;86:703–5.
130.
Balletshofer BM, Rittig K, Enderle MD, et al. Endothelial dysfunction is
detectable in young normotensive first-degree relatives of subjects with type 2
diabetes in association with insulin resistance. Circulation 2000;101:1780–4.
131.
Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S, Silverman F.
Inhalation of fine particulate air pollution and ozone causes acute arterial
vasoconstriction in healthy adults. Circulation 2002;105:1534–6.
132.
Campia U, Choucair WK, Bryant MB, Waclawiw MA, Cardillo C, Panza JA.
Reduced endothelium-dependent and -independent dilation of conductance arteries in
African Americans. J Am Coll Cardiol 2002;40:754–60.
133.
Clarkson P, Mullen MJ, Donald AE, et al. The effect of amlodipine on
endothelial function in young adults with a strong family history of premature
coronary artery disease: a randomised double blind study. Atherosclerosis
2001;154:171–7.
134.
Clarkson P, Adams MR, Powe AJ, et al. Oral L–arginine improves
endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest
1996;97:1989–94.
135.
Clausen P, Jensen JS, Jensen G, Borch-Johnsen K, Feldt-Rasmussen B.
Elevated urinary albumin excretion is associated with impaired arterial dilatory
capacity in clinically healthy subjects. Circulation 2001;103:1869–74.
136.
Djousse L, Ellison RC, McLennan CE, et al. Acute effects of a high-fat meal
with and without red wine on endothelial function in healthy subjects. Am J Cardiol
1999;84:660–4.
137.
Dogra G, Watts GF. Endothelial dysfunction in type 1 diabetes mellitus:
methodological considerations. Diabet Med 2000;17:687–8.
138.
Doshi SN, McDowell IF, Moat SJ, et al. Folate improves endothelial function
in coronary artery disease: an effect mediated by reduction of intracellular
superoxide? Arterioscler Thromb Vasc Biol 2001;21:1196–202.
139.
Evans LM, Davies JS, Anderson RA, et al. The effect of GH replacement
therapy on endothelial function and oxidative stress in adult growth hormone
deficiency. Eur J Endocrinol 2000;142:254–62.
140.
Evans M, Anderson RA, Graham J, et al. Ciprofibrate therapy improves
endothelial function and reduces postprandial lipemia and oxidative stress in type 2
diabetes mellitus. Circulation 2000;101:1773–9.
141.
Fard A, Tuck CH, Donis JA, et al. Acute elevations of plasma asymmetric
dimethylarginine and impaired endothelial function in response to a high-fat meal in
patients with type 2 diabetes. Arterioscler Thromb Vasc Biol 2000;20:2039–44.
142.
Funada J, Sekiya M, Hamada M, Hiwada K. Postprandial elevation of remnant
lipoprotein leads to endothelial dysfunction. Circ J 2002;66:127–32.
143.
Gaenzer H, Neumayr G, Marschang P, et al. Effect of insulin therapy on
endothelium-dependent dilation in type 2 diabetes mellitus. Am J Cardiol
2002;89:431–4.
144.
Gaenzer H, Sturm W, Neumayr G, et al. Pronounced postprandial lipemia
impairs endothelium-dependent dilation of the brachial artery in men. Cardiovasc Res
2001;52:509–16.
145.
Gokce N, Keaney JF, Jr., Frei B, et al. Long-term ascorbic acid administration
reverses endothelial vasomotor dysfunction in patients with coronary artery disease.
Circulation 1999;99:3234–40.
146.
Greiner DZ, Personius BE, Andrews TC. Effects of withdrawal of chronic
estrogen therapy on brachial artery vasoreactivity in women with coronary artery
disease. Am J Cardiol 1999;83:247–9.
147.
Herman SM, Robinson JT, McCredie RJ, Adams MR, Boyer MJ, Celermajer
DS. Androgen deprivation is associated with enhanced endothelium–dependent
dilatation in adult men. Arterioscler Thromb Vasc Biol 1997;17:2004–9.
148.
Hijmering ML, Stroes ES, Olijhoek J, Hutten BA, Blankestijn PJ, Rabelink
TJ. Sympathetic activation markedly reduces endothelium-dependent, flow-mediated
vasodilation. J Am Coll Cardiol 2002;39:683–8.
149.
Hirashima O, Kawano H, Motoyama T, et al. Improvement of endothelial
function and insulin sensitivity with vitamin C in patients with coronary spastic
angina: possible role of reactive oxygen species. J Am Coll Cardiol 2000;35:1860–6.
150.
Hoffmann U, Dirisamer A, Heher S, Kostner K, Widhalm K, Neunteufl T.
Relation of peripheral flow-mediated vasodilatation and coronary arterial calcium in
young patients with heterozygous familial hypercholesterolemia. Am J Cardiol
2002;90:70–3.
151.
Hurlimann D, Forster A, Noll G, et al. Anti-tumor necrosis factor-alpha
treatment improves endothelial function in patients with rheumatoid arthritis.
Circulation 2002;106:2184–7.
152.
Irace C, Ceravolo R, Notarangelo L, et al. Comparison of endothelial function
evaluated by strain gauge plethysmography and brachial artery ultrasound.
Atherosclerosis 2001;158:53–9.
153.
Jartti L, Ronnemaa T, Kaprio J, et al. Population-based twin study of the
effects of migration from Finland to Sweden on endothelial function and intimamedia thickness. Arterioscler Thromb Vasc Biol 2002;22:832–7.
154.
Koh KK, Son JW, Ahn JY, et al. Comparative effects of diet and statin on NO
bioactivity and matrix metalloproteinases in hypercholesterolemic patients with
coronary artery disease. Arterioscler Thromb Vasc Biol 2002;22:e19–e23.
155.
Koh KK, Son JW, Ahn JY, et al. Effect of hormone replacement therapy on
nitric oxide bioactivity and monocyte chemoattractant protein-1 levels. Int J Cardiol
2001;81:43–50.
156.
Komatsu M, Kawagishi T, Emoto M, et al. ecNOS gene polymorphism is
associated with endothelium-dependent vasodilation in type 2 diabetes. Am J Physiol
Heart Circ Physiol 2002;283:H557–61.
157.
Kugiyama K, Motoyama T, Doi H, et al. Improvement of endothelial
vasomotor dysfunction by treatment with alpha-tocopherol in patients with high
remnant lipoproteins levels. J Am Coll Cardiol 1999;33:1512–8.
158.
Lupattelli G, Marchesi S, Roscini AR, et al. Direct association between high-
density lipoprotein cholesterol and endothelial function in hyperlipemia. Am J Cardiol
2002;90:648–50.
159.
Ma LN, Zhao SP, Gao M, Zhou QC, Fan P. Endothelial dysfunction
associated with left ventricular diastolic dysfunction in patients with coronary heart
disease. Int J Cardiol 2000;72:275–9.
160.
Malik J, Melenovsky V, Wichterle D, Haas T, Simek J, Ceska R et al. Both
fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia
(fenofibrate versus atorvastatin trial––FAT). Cardiovasc Res 2001;52:290–8.
161.
Mather KJ, Verma S, Corenblum B, Anderson TJ. Normal endothelial
function despite insulin resistance in healthy women with the polycystic ovary
syndrome. J Clin Endocrinol Metab 2000;85:1851–6.
162.
McCrohon JA, Woo KS, Celermajer DS. A comparison of endothelial
function in Caucasian and Chinese women before and after the menopause. Maturitas
2000;35:31–7.
163.
McCrohon JA, Walters WA, Robinson JT, et al. Arterial reactivity is enhanced
in genetic males taking high dose estrogens. J Am Coll Cardiol 1997;29:1432–6.
164.
Motoyama T, Kawano H, Kugiyama K, et al. Endothelium-dependent
vasodilation in the brachial artery is impaired in smokers: effect of vitamin C. Am J
Physiol 1997;273:H1644–50.
165.
Nightingale AK, James PP, Morris-Thurgood J, et al. Evidence against
oxidative stress as mechanism of endothelial dysfunction in methionine loading
model. Am J Physiol Heart Circ Physiol 2001;280:H1334–9.
166.
Paolisso G, Manzella D, Tagliamonte MR, et al. The BB–paraoxonase
genotype
is
associated
with
impaired
brachial
reactivity
after
acute
hypertriglyceridemia in healthy subjects. J Clin Endocrinol Metab 2001;86:1078–82.
167.
Parchure N, Zouridakis EG, Kaski JC. Effect of azithromycin treatment on
endothelial function in patients with coronary artery disease and evidence of
Chlamydia pneumoniae infection. Circulation 2002;105:1298–303.
168.
Pfeifer M, Verhovec R, Zizek B, Prezelj J, Poredos P, Clayton RN. Growth
hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient
adults. J Clin Endocrinol Metab 1999;84:453–7.
169.
Raitakari OT, McCredie RJ, Witting P, et al. Coenzyme Q improves LDL
resistance to ex vivo oxidation but does not enhance endothelial function in
hypercholesterolemic young adults. Free Radic Biol Med 2000;28:1100–5.
170.
Rajagopalan S, Brook R, Mehta RH, Supiano M, Pitt B. Effect of losartan in
aging-related endothelial impairment. Am J Cardiol 2002;89:562–6.
171.
Rinder MR, Spina RJ, Ehsani AA. Enhanced endothelium-dependent
vasodilation in older endurance-trained men. J Appl Physiol 2000;88:761–6.
172.
Rywik TM, Blackman MR, Yataco AR, et al. Enhanced endothelial
vasoreactivity in endurance-trained older men. J Appl Physiol 1999;87:2136–42.
173.
Sorensen MB, Collins P, Ong PJ, et al. Long–term use of contraceptive depot
medroxyprogesterone acetate in young women impairs arterial endothelial function
assessed by cardiovascular magnetic resonance. Circulation 2002;106:1646–51.
174.
Tan KC, Ai VH, Chow WS, Chau MT, Leong L, Lam KS. Influence of low
density lipoprotein (LDL) subfraction profile and LDL oxidation on endotheliumdependent and independent vasodilation in patients with type 2 diabetes. J Clin
Endocrinol Metab 1999;84:3212–6.
175.
Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend
JN. Does folic acid decrease plasma homocysteine and improve endothelial function
in patients with predialysis renal failure? Circulation 2000;102:871–5.
176.
Thorne S, Mullen MJ, Clarkson P, Donald AE, Deanfield JE. Early endothelial
dysfunction in adults at risk from atherosclerosis: different responses to L-arginine. J
Am Coll Cardiol 1998;32:110–6.
177.
Toikka JO, Laine H, Ahotupa M, et al. Increased arterial intima-media
thickness and in vivo LDL oxidation in young men with borderline hypertension.
Hypertension 2000;36:929–33.
178.
Tomiyama H, Kimura Y, Okazaki R, et al. Close relationship of abnormal
glucose tolerance with endothelial dysfunction in hypertension. Hypertension
2000;36:245–9.
179.
van Dijk RA, Rauwerda JA, Steyn M, Twisk JW, Stehouwer CD. Long–term
homocysteine-lowering treatment with folic acid plus pyridoxine is associated with
decreased blood pressure but not with improved brachial artery endotheliumdependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebocontrolled trial. Arterioscler Thromb Vasc Biol 2001;21:2072–9.
180.
Vita JA, Frei B, Holbrook M, Gokce N, Leaf C, Keaney JF, Jr. L-2-
Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with
coronary artery disease. J Clin Invest 1998;101:1408–14.
181.
Vogel RA, Corretti MC, Plotnick GD. Effect of a single high-fat meal on
endothelial function in healthy subjects. Am J Cardiol 1997;79:350–4.
182.
Watts GF, Playford DA, Croft KD, Ward NC, Mori TA, Burke V. Coenzyme
Q(10) improves endothelial dysfunction of the brachial artery in type II diabetes
mellitus. Diabetologia 2002;45:420–6.
183.
Woo KS, Chook P, Chan LL, et al. Long-term improvement in homocysteine
levels and arterial endothelial function after 1-year folic acid supplementation. Am J
Med 2002;112:535–9.
184.
Woodman RJ, Watts GF, Puddey IB, et al. Leukocyte count and vascular
function in type 2 diabetic subjects with treated hypertension. Atherosclerosis
2002;163:175–81.
185.
Smith JC, Evans LM, Wilkinson I, et al. Effects of GH replacement on
endothelial function and large-artery stiffness in GH-deficient adults: a randomized,
double-blind, placebo-controlled study. Clin Endocrinol (Oxf) 2002;56:493–501.
186.
Hale G, Paul-Labrador M, Dwyer JH, Merz CN. Isoflavone supplementation
and endothelial function in menopausal women. Clin Endocrinol (Oxf) 2002;56:693–
701.
187.
Woo KS, McCrohon JA, Chook P, et al. Chinese adults are less susceptible
than whites to age-related endothelial dysfunction. J Am Coll Cardiol 1997;30:113–8.
188.
Hershkovitz E, Donald A, Mullen M, Lee PJ, Leonard JV. Blood lipids and
endothelial function in glycogen storage disease type III. J Inherit Metab Dis
1999;22:891–8.
189.
Marchesi S, Lupattelli G, Siepi D, et al. Oral L-arginine administration
attenuates postprandial endothelial dysfunction in young healthy males. J Clin Pharm
Ther 2001;26:343–9.
190.
Lupattelli G, Lombardini R, Schillaci G, et al. Flow-mediated vasoactivity and
circulating adhesion molecules in hypertriglyceridemia: association with small, dense
LDL cholesterol particles. Am Heart J 2000;140:521–6.
191.
Matsuda Y, Akita H, Terashima M, Shiga N, Kanazawa K, Yokoyama M.
Carvedilol improves endothelium-dependent dilatation in patients with coronary
artery disease. Am Heart J 2000;140:753–9.
192.
Title LM, Cummings PM, Giddens K, Genest JJ, Jr., Nassar BA. Effect of
folic acid and antioxidant vitamins on endothelial dysfunction in patients with
coronary artery disease. J Am Coll Cardiol 2000;36:758–65.
193.
Celermajer DS, Sorensen KE, Barley J, Jeffrey S, Carter N, Deanfield J.
Angiotensin–converting enzyme genotype is not associated with endothelial
dysfunction in subjects without other coronary risk factors. Atherosclerosis
1994;111:121–6.
194.
Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS.
Association of maternal endothelial dysfunction with preeclampsia. JAMA
2001;285:1607–12.
195.
Corretti MC, Plotnick GD, Vogel RA. The effects of age and gender on
brachial artery endothelium–dependent vasoactivity are stimulus-dependent. Clin
Cardiol 1995;18:471–6.
196.
Hashimoto M, Akishita M, Eto M, et al. The impairment of flow-mediated
vasodilatation in obese men with visceral fat accumulation. Int J Obes Relat Metab
Disord 1998;22:477–84.
197.
Jensen-Urstad K, Johansson J, Jensen-Urstad M. Vascular function correlates
with risk factors for cardiovascular disease in a healthy population of 35-year-old
subjects. J Intern Med 1997;241:507–13.
198.
Kimura Y, Matsumoto M, Miyauchi E, Deng YB, Iwai K, Hattori H.
Noninvasive detection of endothelial dysfunction in elderly with NIDDM by
ultrasonography. Echocardiography 2001;18:559–64.
199.
Motoyama T, Kawano H, Hirai N, et al. The relationship of left ventricular
mass to endothelium-dependent vasodilation of the brachial artery in patients with
hypertension. Cardiology 2001;96:7–15.
200.
Ng CK, Chan AP, Cheng A. Impairment of endothelial function––a possible
mechanism for atherosclerosis of a high-fat meal intake. Ann Acad Med Singapore
2001;30:499–502.
201.
Ringqvist A, Jonason T, Leppert J, Ringqvist I. Non-invasive investigation of
endothelium-dependent dilatation of the brachial artery in women with primary
Raynaud’s phenomenon. Clin Sci (Lond) 1998;94:239–43.
202.
Uehata A, Lieberman EH, Gerhard MD, et al. Noninvasive assessment of
endothelium-dependent flow-mediated dilation of the brachial artery. Vasc Med
1997;2:87–92.
203.
Yildirir A, Tokgozoglu SL, Oduncu T, et al. Soy protein diet significantly
improves endothelial function and lipid parameters. Clin Cardiol 2001;24:711–6.
204.
Zhao SP, Liu L, Gao M, Zhou QC, Li YL, Xia B. Impairment of endothelial
function after a high-fat meal in patients with coronary artery disease. Coron Artery
Dis 2001;12:561–5.